Augmedix, Inc. (AUGX)
NASDAQ: AUGX · IEX Real-Time Price · USD
2.260
+1.344 (146.62%)
At close: Jul 19, 2024, 4:00 PM
2.270
+0.010 (0.44%)
Pre-market: Jul 22, 2024, 7:33 AM EDT
Augmedix Market Cap
Augmedix has a market cap or net worth of $110.67 million as of July 22, 2024. Its market cap has decreased by -44.80% in one year.
Market Cap
110.67M
Enterprise Value
98.93M
1-Year Change
-44.80%
Ranking
Category
Stock Price
$2.26
Market Cap Chart
Since March 31, 2021, Augmedix's market cap has decreased from $134.30M to $110.67M, a decrease of -17.60%. That is a compound annual growth rate of -5.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 110.70M | -54.26% |
| Dec 29, 2023 | 242.00M | 314.38% |
| Dec 30, 2022 | 58.40M | -50.09% |
| Dec 31, 2021 | 117.00M | -12.88% |
| Mar 31, 2021 | 134.30M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TELA Bio | 114.15M |
| aTyr Pharma | 113.18M |
| Telomir Pharmaceuticals | 111.04M |
| Karyopharm Therapeutics | 110.91M |
| Adagene | 110.74M |
| I-Mab | 110.14M |
| Elutia | 110.10M |
| Journey Medical | 109.27M |